Login / Signup

Updated pharmacokinetic considerations for the use of antimalarial drugs in pregnant women.

Brioni R MooreTimothy M E Davis
Published in: Expert opinion on drug metabolism & toxicology (2020)
Changes in antimalarial drug disposition in pregnancy are well described, yet pregnant women continue to receive treatment regimens optimized for non-pregnant adults. Contemporary in silico modeling has recently identified a series of alternative dosing regimens that are predicted to provide optimal therapeutic efficacy for pregnant women.
Keyphrases
  • pregnant women
  • pregnancy outcomes
  • plasmodium falciparum
  • molecular docking
  • preterm birth
  • emergency department
  • drug induced
  • combination therapy
  • smoking cessation